Optimizing Quality with Virtual solutions

At Virtual Quality Partners, we tailor our full GxP service offering to each specific clients needs, supporting small/medium biotech and pharmaceutical companies, particularly those entering the EU and US markets, with our agile and operational solutions.

Close-up of a bubble against a black background, showing iridescent colors on the surface.

GDP RP/DRP Event - Contract RP Case Study Q4 2025

Brand new VQP RP/DRP Refresher Training 1 day course - November 2025. Following a HPRA inspection, significant GDP compliance deficiencies were identified at a Dublin-based wholesaler. Are you up to the task, as the newly onboarded contract RP, focused on restoring the sites reputation and GDP compliance? Can you bring the company through an effective remediation plan?

Book

It’s IMP/Clinical Product – GDP Principles Don’t Apply, Right?

VQP challenge a common misconception that GDP doesn’t apply to investigational medicinal products. Drawing on EMA guidance, VQP explain why a similar quality mindset must extend to IMPs — from secure shipping and temperature monitoring to full traceability and risk management.

Read More Here

Are You Procuring or Supplying Medicinal Products?

Many pharmaceutical companies today operate virtual business models, outsourcing storage and distribution while retaining full responsibility for product quality. In this short video, VQP explain how Good Distribution Practice (GDP) obligations apply to virtual companies, and the key steps needed to maintain HPRA compliance.

Watch More Here

Core Services

Close-up of a building with a pattern of rectangular window openings and protruding concrete frames.

Virtual Quality Department

Your full service, outsourced Quality team effectively managing your Quality Systems, Quality Compliance and Quality Operations functions tailored for all Pharma and Biotech sized companies.

Close-up of a person's hand typing on a laptop keyboard in black and white.

Streamline EU Market Entry and product distribution setup, with an expert led, full RP service offering to manage launch and oversight of your medicinal product Distribution activities in EU/EEA

EU Market Entry and Distribution

Empty conference room table with five chairs, notebooks, pens, and pencils, in front of a large window overlooking a cityscape.

For Non-EU or startup companies entering the EU market without local infrastructure, we enable seamless EU market entry with end to end Marketing Authorization Holder (MAH) services.

Virtual MAH Function

Learn More

Our Leadership Team

Headshot of a smiling man with short dark hair and blue eyes, wearing a purple button-up shirt against a plain light background.

  • Dr. Fitzgerald brings over 25 years of experience in the pharmaceutical industry, with a strong background in Technical Operations across the product lifecycle. For the past 15+ years, he has served as Head of Quality for organizations holding Clinical (IMPD/IND) and Commercial (MA/NDA/BLA) product authorizations. He is an active contract Responsible Person (RP) ensuring robust regulatory compliance and operational oversight and has hosted multiple Regulatory inspections (HPRA PAI WDA/MIA/MIA IMP, MHLW/PMDA MA) over the past 10+ years with no major findings.

Portrait of a man with glasses, a red beard, and short brown hair, wearing a gray sweater and plaid shirt, against a plain light gray background.

  • Padraig Long has over 18 years of experience in the pharmaceutical industry, specializing in Quality Operations across both small and large molecule programs. He is an experienced Qualified Person (QP) for companies holding Clinical (IMPD/IND) and Commercial (MA/NDA/BLA) authorizations, with responsibility for batch certification and ensuring full compliance with the terms of each company’s Manufacturing and Importation Authorisation (MIA).